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Protection of human participants in health research – a 
comparison of some US federal regulations and South African 
research ethics guidelines
P Cleaton-Jones, D Wassenaar
In response to criticism of ethical review of a South African clinical 
trial, we contrast aspects of the United States Common Rule 
with South African research ethics requirements. In the USA the 
Common Rule does not apply to all health research and allows many 
exemptions from ethics review and waivers of informed consent. At 
a structural level research ethics review in South Africa is in many 
cases equivalent to the US institutional review board (IRB) and Office 
for Human Research Protections (OHRP) oversight system, is wider 
reaching, and has no exclusions.
Introduction
Philpott and Schüklenk posted a blog on the website of the Bioethics 
Forum of the Hastings Centre1 criticising a clinical trial in South 
Africa published in February 2010 in the New England Journal of 
Medicine.2 They had concerns with the trial, believing that it violated 
both ‘... ethical study design ...’ and ‘... the Declaration of Helsinki’s 
requirements on standards of care ...’.1 Thereafter an article in Science3 
commented on pros and cons of the trial and criticism of the trial and 
the arguments of Philpott and Schüklenk.1 
Comments by Philpott and Schüklenk of concern to us regarding 
ethical review of the trial are:1
•    ‘... serious concerns about the quality of ethical review in 
developing countries like South Africa ...’
•    ‘Organisations ... have directed millions of dollars to train 
members of African ethical review committees and yet this trial 
was reviewed and approved by a committee in South Africa.’
•    ‘... some surprising deficiencies in existing US regulations regarding 
when ethical review should be undertaken by American IRBs ...’. 
Another paper4 critical of the same study in the New England 
Journal of Medicine2 also recommends revision of the South African 
ethics review system, and in particular suggests that international 
assistance should be sought, especially for interventional studies, in 
the hope that ethical problems would be more adequately identified 
before approval.
The authors of the present paper both chair research ethics 
committees (RECs) in South Africa that are registered with the South 
African National Health Research Ethics Council (see http://www.
doh.gov.za/nhrec/) and have US Federalwide Assurance with the US 
OHRP (see http://www.hhs.gov/ohrp/assurances/assurances_index.
html). DW also directs the South African Research Ethics Training 
Initiative (SARETI), a US NIH-Fogarty International Center-
sponsored master’s-level research ethics training programme for REC 
members and researchers from African countries. 
We are concerned about the insinuation that research ethics 
review and training in research ethics are substandard in South 
Africa. This could adversely affect perceptions of existing and 
potential international research collaborators from the USA and 
other developed countries. We therefore provide background on 
research ethics review and training in South Africa based on our 
approximately 50 years of experience in research ethics, and highlight 
some differences between South African and US federal guidelines on 
research ethics.
History of research ethics committees 
in South Africa
Beecher’s 1966 article in the New England Journal of Medicine5 
had an effect in South Africa, as elsewhere in the world. In 1996, 
having read Beecher’s views, John Hansen, professor of paediatrics 
at the University of the Witwatersrand, persuaded his university to 
set up an REC based in the medical faculty, which has functioned 
continuously ever since. From 1977 onwards other universities in 
South Africa, the Department of Health (DOH), the Human Sciences 
Research Council (HSRC), the Medical Research Council (MRC), 
the pharmaceutical industry, the South African Medical Association, 
and bodies such as individual hospitals formed RECs (Table I). The 
MRC was the first to issue South African guidelines on ethics in 
health research,6 followed by the DOH7 and the HSRC8 (Table I). This 
timeline is similar to organisations elsewhere, e.g. the US National 
Institutes of Health,9 particularly after the publication of the Belmont 
Report in the USA10 (Table II).
Initially, compliance with ethical clearance of health research 
was a moral decision for South African researchers, reinforced by 
internal regulations of the various institutions mentioned above. 
This changed in 1996 with the passing into law of the South African 
Constitution, which states: 
‘... Everyone has the right to bodily and psychological integrity, 
which includes the right: 
a) to make decisions concerning reproduction;
b) to security in and control over their body; and
c) not to be subjected to medical or scientific experiments without 
their informed consent.’11
This entrenchment of informed consent in a national constitution 
is the only one in the world. 
The National Health Act became law in 2005, making the prior 
ethical approval of research by a registered REC a legal requirement.12 
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The Act also defines a National Health Research Ethics Council 
(NHREC) with the following duties:
‘72. ...
(6) The National Health Research Ethics Council must –
(a)  determine guidelines for the functioning of health research 
ethics committees;
(b) register and audit health research ethics committees;
(c)  set norms and standards for conducting research on humans 
and animals, including norms and standards for conducting 
clinical trials;
(d)  adjudicate complaints about the functioning of health research 
ethics committees and hear any complaint by a researcher who 
believes that he or she has been discriminated against by a 
health research ethics committee;
(e)  refer to the relevant statutory health professional council 
matters involving the violation or potential violation of an 
ethical or professional rule by a health care provider;
(f)  institute such disciplinary action as may be prescribed against 
any person found to be in violation of any norms and standards, 
or guidelines, set for the conducting of research in terms of this 
Act; and 
(g)  advise the national department and provincial departments on 
any ethical issues concerning research ...’12
This Council is the equivalent of the US OHRP13 but has wider 
reach and greater powers. There are important differences between 
the US OHRP’s reach and that of the SA NHREC. ‘The OHRP has 
jurisdiction over research funded by or supported by the Department 
of Health and Human Services, for research conducted either in the 
US or in other countries. For research that is funded or conducted 
by DHHS within the US, institutions may voluntarily decide to apply 
the Common Rule14 to all research, regardless of funding source (E 
Bartlett, personal communication, 1 July 2010).  A similar situation 
prevails in Canada.15 This voluntary use of the Common Rule for 
non-federally funded research implies to us that regulation and ethics 
oversight of non-federally funded research in the USA are not subject 
to any statutory, nationally monitored supervision. This system 
regarding the ethics review of health research is therefore less well 
regulated, especially for non-federally funded research in non-federal 
research organisations, than in South Africa. Non-federal institutions 
in the USA (and elsewhere) may choose to adopt the Common Rule 
and seek OHRP federal-wide assurance, but this is not mandatory 
unless authority to review US federally funded studies is sought. In 
contrast, the South African Health Act requires that all health-related 
(including social and behavioural) research conducted in South Africa 
must be reviewed by an REC that is registered with the NHREC, and 
must comply with the provisions of the South African Research 
Ethics guidelines7 and with the South African guidelines on good 
clinical practice (GCP).16 Two additional laws must also be complied 
with – the Children’s Act17 and the Sexual Offences Act.18 We know of 
no federal law in the USA requiring mandatory registration of every 
IRB that reviews research with human participants.
These important differences suggest that there is generally wider 
mandatory oversight of health-related research in South Africa than 
in the USA. Philpott and Schüklenk’s allegation that oversight in 
South Africa may be inferior is surprising in view of comments in an 
earlier editorial entitled ‘Bioethical colonialism?’19 in which Chadwick 
and Schüklenk were critical of attempts by ‘international agencies’ to 
‘… improve research ethics capacity in the developing world’. Now 
there is a paradoxical appeal from Philpott and Schüklenk1 to the 
same ‘… colonialist thinking …’19 to impose superior US oversight on 
autonomous ethical review by an African country for studies such as 
the SAPIT study.2
Table I. Timeline for research ethics in South Africa 
Year Comment
1966 June – Beecher’s NEJM article
October – University of the Witwatersrand forms 
REC
1977+ South African universities and MRC form RECs
1979 SA MRC issues research ethics guidelines (revised 
1987, 1993, 2002 - 2005)
1992 SAMA establishes REC
1995 Pharma ethics REC established
1996 SA Constitution entrenches informed consent to 
participate in research in Bill of Rights
2000 SA DoH issues clinical trial GCP guidelines 
(revised 2006)
2004 SA DoH issues research ethics guidelines
US OHRP does quality assurance site visits at 6 SA 
university RECs
2005 National Health Act No. 61 of 2003 makes REC 
approval compulsory
2006 SA National Health Research Ethics Council 
established
2008 Compulsory registration of SA RECs with NHREC
DoH public list of clinical trials compulsory
2010 Audit of SA RECs by NHREC
MRC = Medical Research Council; REC = research ethics committee; SAMA = South 
African Medical Association; DoH = National Department of Health; GCP = good clini-
cal practice; NHREC = National Health Research Ethics Council.
Table II. Evolution of ethics review in the USA9
Year Comment
1953 NIH intramural clinical research to be screened by 
Protection of Human Subjects Review Panel
1966 June – Beecher’s NEJM article
US Public Health Service IRB system established, 
screening extended to extramural research
1974 National Research Act, IRB screening of all 
research, human research regulations 45 CFR 46 
developed
1979 Belmont Report, national legal requirement for IRB 
review
1981 Health and Human Services provided framework 
for IRB function and revision of 45 CFR 46
1981 - 2009 Intermittent revision of 45 CFR 46
IRB = institutional review board.
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Table III. Comparison of exemption sections of US Common Rule with South African law/ethics guidelines 
Ethical issue US common law/ethics guidelines SA law/ethics guidelines
Protection of human research subjects Subpart A National Health Act No. 61 of 200312
[Note: Exemptions are in (b) (1) though (5). 
Sections (2) (4) and (5) differ between the 
countries.]
Basic HHS Policy for Protection of Human 
Research Subjects
Authority: 5 U.S.C. 301; 42 U.S.C. 289; 42 
U.S.C. 300v-1(b).
Source: 56 FR 28012, 28022, 18 June 1991, 
unless otherwise noted.
(b) (2) (4) (5) require ethics approval
‘46.101 To what does this policy apply?
(a) Except as provided in paragraph (b) of 
this section, this policy applies to all research 
involving human subjects conducted, 
supported or otherwise subject to regulation 
by any federal department or agency which 
takes appropriate administrative action to 
make the policy applicable to such research ...
(b) Unless otherwise required by department 
or agency heads, research activities in which 
the only involvement of human subjects will 
be in one or more of the following categories 
are exempt from this policy:
(1) ...
(2) Research involving the use of educational 
tests (cognitive, diagnostic, aptitude, 
achievement), survey procedures, interview 
procedures or observation of public behavior, 
unless:
 (i) information obtained is recorded in 
such manner that human subjects can be 
identified, directly or through identifiers 
linked to the subjects; and
 (ii) any disclosure of the human subjects’ 
responses outside the research could 
reasonably place the subjects at risk of 
criminal or civil liability or be damaging 
to the subjects’ financial standing, 
employability, or reputation.
(3) ...
(4) Research involving the collection or 
study of existing data, documents, records, 
pathological specimens, or diagnostic 
specimens, if these sources are publicly 
available or if the information is recorded 
by the investigator in such a manner that 
subjects cannot be identified, directly or
through identifiers linked to the subjects.
(5) Research and demonstration projects 
which are conducted by or subject to the 
approval of department or agency heads, 
and which are designed to study, evaluate, or 
otherwise examine:
 (i) Public benefit or service programs;
 (ii) procedures for obtaining benefits or 
services under those programs;
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Background on research ethics 
training in South Africa
In 2002 two applications for research ethics training grants from the 
Fogarty International Center of the National Institutes of Health were 
successful. The International Research Ethics Network of Southern 
Africa (IRENSA) (see http://www.irensa.org) was established at the 
University of Cape Town under Professor S Benatar, and SARETI (see 
http:shsph.up.ac.za/sareti.htm) was formed jointly at the universities 
of Pretoria and KwaZulu-Natal by Professors C IJsselmuiden and 
D Wassenaar in collaboration with the Johns Hopkins University, 
Berman Institute of Bioethics. While these both aim to increase 
research ethics capacity, they have different emphases.20 A third body, 
formed at the same time but without NIH support, was a Division of 
Bioethics at the University of the Witwatersrand headed by Professor 
U Schüklenk, now the Steve Biko Centre for Bioethics headed 
by Professor A Dhai (see http://web.wits.ac.za/Academic/Health/
Entities/Bioethics/).
In addition, all registered (licensed) health professionals in South 
Africa must obtain 30 continuing education units (CEUs) annually to 
maintain their professional registration, and at least 5 CEUs must be 
in professional ethics. South Africa also formally endorses the ICH 
(International Committee on Harmonisation) requirements for GCP in 
research, requiring that all investigators and senior personnel in clinical 
trials have valid GCP certification. There is an active GCP training 
environment in South Africa. The NHREC has recently taken steps 
to accredit GCP service providers to ensure that minimum standards 
are required when GCP certification is provided, and a process to set 
minimum training standards is currently underway.
Given this information, we contend that allegations that research 
ethics review in South Africa is sub-standard are ill informed and 
unsupported. Evidence suggests that with the promulgation of the 
current Health Act and the statutory oversight of the NHREC, 
requiring registration and compliance of all South African RECs, 
and ethics review of all health and related research in South Africa, 
there are fewer loopholes for the conduct of inadequately reviewed 
research than in many developed countries.21,22 Indeed several 
OHRP-approved RECs (IRBs) at several prestigious US institutions 
have been suspended over the past decade or more because of 
demonstrable harm to human participants,15,23-26 suggesting that 
human participant protection in the USA is not as superior as 
Philpott and Schüklenk argue. 
Questions can still be asked about the quality of ethics review 
within a registered REC, but these are not unique to South Africa 
and are the subject of current global discussion – viz., what are valid 
performance indicators of competent ethics review procedures? 
The fact that a committee approves a controversial study is not 
necessarily a sign of incompetence; it may be the result of a careful 
consideration of equipoise, social value and scientific validity, and a 
careful risk/benefit determination. Questions can also be asked about 
the merits of conservative risk-avoidant ethics review processes that 
Table III. Comparison of exemption sections of US Common Rule with South African law/ethics guidelines (continued)
Ethical issue US common law/ethics guidelines SA law/ethics guidelines
 (iii) possible changes in or alternatives to 
those programs or procedures; or
 (iv) possible changes in methods or levels 






(g) This policy does not affect any foreign 
laws or regulations which may otherwise 
be applicable and which provide additional 
protections to human subjects of research.
(h) When research covered by this policy 
takes place in foreign countries, procedures 
normally followed in the foreign countries 
to protect human subjects may differ from 
those set forth in this policy ...
In these circumstances, if a department or 
agency head determines that the procedures 
prescribed by the institution afford 
protections that are at least equivalent to 
those provided in this policy, the department 
or agency head may approve the substitution 
of the foreign procedures in lieu of the 
procedural requirements provided in this 
policy.’
715November 2010, Vol. 100, No. 11  SAMJ
FORUM
stifle socially valuable research and limit important developments in 
public health. 
Comparisons between some US 
federal regulations and legal/ethical 
requirements in South Africa 
Table III contrasts differences in waiver policy in the USA under 
the US Common Rule (45 CFR 46)14 and South African national 
guidance7 and laws11,12 to indicate where more stringency is required 
in South Africa.
Surveys, interview procedures and behavioural studies, unless 
identifiable or potentially harmful, are exempted from ethics review 
in the USA in section (2) of 46.101 of the Common Rule. All of these 
types, whether in educational institutions or not, require ethical 
review in South Africa. 
While the study of existing data in the public domain (section 
4) is exempted in both countries, collection of other records must 
be cleared by an REC in South Africa. Under the same section, the 
Common Rule also exempts pathological and diagnostic specimens, 
which is not the case in South Africa. Should a researcher collect 
blood in a study that is granted ethical clearance in the USA, for 
example, he or she may share the sample with colleagues doing other 
research without clearance by an IRB (REC). Not so in South Africa, 
where each use of collected specimens must be scrutinised and 
approved by an REC in relation to the original protocol and informed 
consent. Recently the Havasupai Indian tribe successfully sued the 
University of Arizona for doing research other than the originally 
agreed diabetes mellitus investigation.27 The South African system 
prohibits similar unauthorised use of existing specimens. 
Another important area of difference concerns informed consent 
(Table IV). The US Common Rule permits consent to be waived under 
several circumstances. In South Africa the possibility of a waiver is 
very limited. Similarly, there are differences in documentation of 
consent and age of consent for minors. In each instance the South 
African requirements are more stringent.
Conclusion
We fully agree with Boulle et al.4 that further training for RECs 
should be improved – however, this is a global issue and not unique 
to South Africa, which is relatively well resourced with research ethics 
training facilities. The SA NHREC guidelines require that all REC 
members receive initial and ongoing training in research ethics, so 
this point is uncontroversial. A more important point is to get RECs’ 
host institutions globally to resource their RECs to better equip them 
to refine the complex balancing act of advancing important health 
research while maximising the protection of vulnerable participants.
While the points made above regarding the structural, legal and 
ethical requirements for ethics review of research in South Africa 
Table IV. Comparison of aspects of informed consent in the US Common Rule and South African law and guidelines
Ethical issue US Common Rule SA law/ethics guidelines
Informed consent
Documentation of informed consent
Additional protection for children
46.116 Informed consent14
Waiver is possible if research involves 
no more than minimal risk and the 
waiver will not affect the rights and 
welfare of subjects
Waiver is possible if research could not 
practicably be carried out without the 
waiver
Waiver is possible if subjects will be 
given additional pertinent information 
after participation
Note: But local laws apply to make 
consent legally effective
46.117 Documentation of informed 
consent14
For written consent information may 
be read to a subject
Signed consent may be waived if this 
could cause harm through breach of 
confidentiality, if the research involves 
no more than minimal risk and has no 
procedures for which written consent 
would normally be required
Subpart D Additional protection for 
children 46.402 Definitions14
Children are persons who have not 
attained the legal age for consent to 
treatments or for procedures involved 
in the research according to the 
applicable law
Informed consent must adhere to the SA 
Constitution11 and the National Health Act12
A waiver is possible only in some limited 
circumstances for stored information
Written consent is the norm according to the 
National Health Act;12 verbal consent is the 
exception
For research children are persons younger 
than 18 years
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do not necessarily prevent poor-quality review from occurring, we 
argue that at a structural level ethics review in South Africa is in 
many cases equivalent to that provided by the US IRB and OHRP 
oversight system, and indeed is wider reaching and has no exclusions. 
The NHREC is soon to embark on a process of auditing all registered 
South African RECs, which will further ensure that the quality of 
review is at least equivalent to the best international standards. 
Ms D Marais and Ms N Mamotte are thanked for bibliographical 
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